Patrys Limited announced the appointment, effective from the close of 2014 AGM on November 12, 2014, of Dr. James Campbell as a Non-Executive Director. Dr. Campbell was previously the CFO and COO of ChemGenex Pharmaceuticals Limited with responsibilities ranging from IP management through to licensing and business development. More recently Dr. Campbell has guided the creation, through acquisition, of Invion Limited as an executive director and remains a non-executive director of that company, and has assisted private biotechnology companies in New Zealand and the USA with capital raising and partnering negotiations.

Dr. Campbell is also a Non-Executive Director of BioProspect Limited.